Genetics Generation Advancement Corp. (TPEX:4160)

Market Cap	1.08B -26.4%
Revenue (ttm)	609.13M -4.6%
Net Income	13.89M -71.1%
EPS	0.57 -68.4%
Shares Out	26.96M
PE Ratio	70.26
Forward PE	n/a
Dividend	1.85 (4.62%)
Ex-Dividend Date	Oct 3, 2025

Volume	65,517
Open	40.00
Previous Close	40.00
Day's Range	40.00 - 40.35
52-Week Range	39.25 - 60.50
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About TPEX:4160

Genetics Generation Advancement Corp. provides genetic testing, molecular and science diagnostics, biotechnology, precision health, and digital innovation services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides bioinformatic, materials sciences, research and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 104
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4160

Financial Performance

In 2025, TPEX:4160's revenue was 603.11 million, a decrease of -8.88% compared to the previous year's 661.86 million. Earnings were 21.37 million, a decrease of -60.93%.